Morgan Stanley maintains an overweight rating on BBDC4 shares, arguing that market concerns regarding Bradesco's capital quality are legitimate—yet overdone. In a report released this week, the firm ran stress tests on the bank's capital and concluded that, even under severe scenarios, there is no evidence of an imminent need for a new share issuance.
Historical low. Morgan Stanley calculates that, based on ROE, fair value would be around 1.3×.
Compared to 25.5% for Itaú (ITUB4). The return gap explains part of the discount, but not all of it.
Bradesco trades below Itaú in tangible book value. Historically, Bradesco has traded at a premium of ~19% over its rival.
Why Is the Market Concerned About Bradesco's Capital?
The core issue is not earnings or loan defaults—it is capital composition. Deferred tax assets (DTAs) account for 54% of Bradesco's equity, according to Morgan Stanley's analysis. DTAs are tax credits accumulated during periods of losses or provisions that were non-deductible when booked, which the bank uses to lower taxes on future profits. They count toward regulatory capital, but rely on future earnings to convert into actual cash: in a severe and prolonged downturn where the bank accumulated losses, these assets would lose value without generating liquidity, eroding the Common Equity Tier 1 (CET1) ratio.
Bradesco is not the only Brazilian bank carrying substantial DTAs, but the concentration stands out compared to its peers. When examining "hard" capital—excluding DTAs, goodwill, and other intangibles—the disparity among the three major private banks and public peers is as follows:
The bars display tangible capital as a proportion of equity: the share of book value remaining after excluding items that do not quickly turn into cash. At just 34%, Bradesco's proportion is less than half that of Itaú—and the market is pricing in a discount precisely because of this gap. In a separate analysis, BofA previously pointed to Itaú as the sector's most secure balance sheet for 2027, while classifying Bradesco as a value play built squarely on that discount.
What Morgan Stanley's Stress Tests Show
Morgan Stanley modeled three scenarios for Bradesco's CET1 ratio through the end of 2027. The current CET1 stands at 12.1%, against a regulatory floor of 8%:
Gradual improvement without shocks. Capital rises by ~70 basis points throughout 2027.
Above the 8% minimum. The bank absorbs the shock without needing to issue shares.
Below the 8% floor—though Morgan Stanley views this scenario as unlikely given the bank's current positioning.
The extreme scenario is included in the report as an exercise in transparency rather than a forecast. Morgan Stanley does not project the bank reaching this level without an unusual, simultaneous deterioration in defaults, earnings, and the macroeconomic environment. Third-quarter 2026 results still showed a recurring net income of R$ 7.1 billion—up 14.6% year-over-year—indicating that the underlying earnings-generation engine remains operational.
The Discount Relative to Itaú Exceeds Levels Seen During the 2016 Crisis
The most revealing part of the report is the historical comparison. In 2016, when Brazil's economy was in a recession with GDP contracting nearly 4% and rising bank default rates, Bradesco posted an ROE of 18.8% and traded close to 1.0× book value. Today, ROE has slipped to 16.6%—lower, but not collapsing—and the stock trades at 0.7×. The current multiple sits below where the shares traded during the country's worst recent macroeconomic cycle.
From a ~19% premium over Itaú to a 30% discount in tangible book value—the sharpest reversal of the past decade.Morgan Stanley, November 2026
Morgan Stanley calculates that, applying the difference in ROE between the two banks (16.6% vs. 25.5%), fair P/B for Bradesco would sit around 1.3×. Even with that profitability discount factored in, the stock trades well below it at 0.7×. The firm's conclusion: the current discount outstrips what the return differential justifies, placing the stock in a valuation band historically associated with peak pessimism.
How the Bank Can Normalize Capital Without Tapping the Market
Morgan Stanley outlines three avenues Bradesco can pursue before considering any new equity raise. The first is earnings retention: with recurring generation of ~R$ 7 billion per quarter, each period of retained profit adds capital to CET1 without requiring regulatory approval or favorable market conditions. The second is asset monetization—the bank already completed a R$ 10 billion capital increase in 2026 and maintains an active share buyback program, which concentrates dividends on remaining shares without requiring additional cash outflows.
The third, and most significant for reducing DTA dependency, is BradSaúde (SAUD3). If the transaction secures regulatory approval, it could convert part of the deferred tax assets into higher-quality capital, instantly adding 140 basis points to the CET1 ratio—effectively lifting it from 12.1% to 13.5%. In that event, the debate surrounding capital risk would conclude ahead of 2027. Itaú, which leads in tangible capital, has also warned that 2027 could prove more challenging—placing both major private banks in the same macroeconomic environment from different starting positions.
Furthermore, Bradesco's operations have gained efficiency without relying on mass layoffs: expenses rose just 3% in the first nine months of 2026, trailing inflation at 5% and coming in well below revenue growth of 11% over the same period. The branch network has contracted by ~33% over the past two years, while headcount dropped by only 8%—a sign that efficiency stems from digitization rather than deep cuts to core operations. Secured lending climbed from 62% to 64% of the total loan portfolio (payroll-deducted loans, auto loans, and mortgages), reducing exposure to more volatile segments should default rates rise.
Morgan Stanley is not arguing that the capital concern is nonexistent—it is arguing that the market is pricing in more than the risk is worth. Investors currently holding BBDC4 own a stock trading at 0.7× book value with a dividend yield above 11%, in a bank growing earnings by 14.6% annually despite a challenging macroeconomic backdrop. The concrete risk is the materialization of the extreme CET1 scenario—a path requiring a sharp surge in defaults alongside plunging earnings, without any capital management tools being deployed. Prospective investors sitting on the sidelines must decide whether they are comfortable with capital uncertainty until BradSaúde gains approval or CET1 climbs organically toward the 13% range.
CET1 in Q4 2026 results — if it rises from 12.1% to above 12.5%, capital pressure eases. A drop below 11.5% would signal a genuine warning not factored into Morgan Stanley's models.
BradSaúde (SAUD3) — regulatory approval instantly adds 140 bps to CET1 and settles the debate over capital adequacy. Without approval, the pressure persists.
Loans past due over 90 days — landed at 4.6% in Q3 2026. If it crosses 5.0%, provisioning requirements rise and erode capital faster than quarterly earnings generation can offset.
Discount vs. Itaú in tangible book value — Morgan Stanley calculates that the fair gap should remain below 10%. A discount above 20% reflects market overreaction; a move toward 10% signals that the recovery thesis is closing.